微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.8% | -82.68% | -32.2% | 34/52 | 3.55% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 1.18% | -65.29% | -15.11% | 28/52 | 2.24% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.39% | -46.12% | -46.95% | 20/52 | 1.22% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 2.62% | 81.94% | -43.29% | 31/52 | 3.83% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 4.62% | 29.05% | 35.88% | 28/52 | 6.78% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 3.4% | 42.26% | 31.78% | 24/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.58% | 5.31% | 79.17% | 17/52 | 2.55% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 1.44% | -80.88% | -59.78% | 35/52 | -0.52% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 3.58% | 2% | 49.79% | 32/52 | 11.21% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 2.39% | -59.22% | -2.45% | 34/52 | 5.46% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 2.45% | 2% | -67.46% | 22/52 | 3.09% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 7.53% | -22.93% | 28.5% | 31/52 | -6.4% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-06-30 | 5.86% | 74.93% | -40.02% | 24/52 | 2.32% | 金域医学 | 43.58% | 行业排名> |
| 2020-12-31 | 9.77% | 16.03% | 191.64% | 30/52 | 10.94% | 金域医学 | 35.41% | 行业排名> |
| 2020-06-30 | 3.35% | 2% | -60.21% | 24/52 | 2.51% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-12-31 | 8.42% | 12.27% | 12.27% | 30/52 | 64.11% | 金域医学 | 13.23% | 行业排名> |
| 2018-12-31 | 7.5% | 66.67% | 66.67% | 27/52 | -0.5% | 万邦医药 | 52.05% | 行业排名> |
| 2017-12-31 | 4.5% | 2% | 2% | 30/52 | 2.03% | 华大基因 | 48.52% | 行业排名> |